EN HU

Potor László

Teljes publikációs lista

2024
1.
Kalló, G., Zaman, K., Potor, L., Hendrik, Z., Méhes, G., Tóth, C., Gergely, P., Tőzsér, J., Balla, G., Balla, J., Prokai, L., Csősz, É.: Identification of Protein Networks and Biological Pathways Driving the Progression of Atherosclerosis in Human Carotid Arteries Through Mass Spectrometry-Based Proteomics.
Int. J. Mol. Sci. 25 (24), 1-21, (cikkazonosító: 13665), 2024.
Folyóirat-mutatók:
Q2 Catalysis (2023)
Q1 Computer Science Applications (2023)
D1 Inorganic Chemistry (2023)
Q1 Medicine (miscellaneous) (2023)
Q2 Molecular Biology (2023)
D1 Organic Chemistry (2023)
Q1 Physical and Theoretical Chemistry (2023)
D1 Spectroscopy (2023)
2023
2.
Combi, Z., Potor, L., Nagy, P., Sikura, K. É., Ditrói, T., Jurányi, E. P., Galambos, K., Szerafin, T., Gergely, P., Whiteman, M., Torregrossa, R., Ding, Y., Beke, L., Hendrik, Z., Méhes, G., Balla, G., Balla, J.: Hydrogen sulfide as an anti-calcification stratagem in human aortic valve: altered biogenesis and mitochondrial metabolism of H2S lead to H2S deficiency in calcific aortic valve disease.
Redox Biol. 60, 1-19, (cikkazonosító: 102629), 2023.
Folyóirat-mutatók:
D1 Biochemistry
D1 Clinical Biochemistry
D1 Organic Chemistry
2022
3.
Gáll, T., Nagy, P., Garai, D., Potor, L., Balla, G. J., Balla, G., Balla, J.: Overview on hydrogen sulfide-mediated suppression of vascular calcification and hemoglobin/heme-mediated vascular damage in atherosclerosis.
Redox Biol. 57, 1-13, 2022.
Folyóirat-mutatók:
D1 Biochemistry
D1 Clinical Biochemistry
D1 Organic Chemistry
2021
4.
Balla, S., Zöld, E., Potor, L., Lukucz, B., Vajas, A., Ujhelyi, B., Nagy, V.: Analysis of intravitreal bevacizumab treatment for macular oedema due to retinal vein occlusion.
Eur. J. Ophthalmol. 31 (5), 2528-2534, 2021.
Folyóirat-mutatók:
Q2 Medicine (miscellaneous)
Q2 Ophthalmology
5.
Pethő, D., Hendrik, Z., Nagy, A., Beke, L., Patsalos, A., Nagy, L., Póliska, S., Méhes, G., Tóth, C., Potor, L., Eaton, J. W., Jacob, H. S., Balla, G., Balla, J., Gáll, T.: Heme cytotoxicity is the consequence of endoplasmic reticulum stress in atherosclerotic plaque progression.
Sci. Rep. 11 (1), 2021.
Folyóirat-mutatók:
D1 Multidisciplinary
6.
Vincze-Fige, É., Szendrei, J., Sós, L., Kraszewska, I., Potor, L., Balla, J., Szondy, Z.: Heme Oxygenase-1 Contributes to Both the Engulfment and the Anti-Inflammatory Program of Macrophages during Efferocytosis.
Cells. 10 (3), 652-669, 2021.
Folyóirat-mutatók:
Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
7.
Sikura, K. É., Combi, Z., Potor, L., Szerafin, T., Hendrik, Z., Méhes, G., Gergely, P., Whiteman, M., Beke, L., Fürtös, I., Balla, G., Balla, J.: Hydrogen sulfide inhibits aortic valve calcification in heart via regulating RUNX2 by NF-[kappa]B, a link between inflammation and mineralization.
J. Adv. Res. 27, 165-176, 2021.
Folyóirat-mutatók:
D1 Multidisciplinary
8.
Potor, L., Hendrik, Z., Patsalos, A., Katona, É., Méhes, G., Póliska, S., Csősz, É., Kalló, G., Komáromi, I., Combi, Z., Posta, N., Sikura, K. É., Pethő, D., Oros, M., Vereb, G., Tóth, C., Gergely, P., Nagy, L., Balla, G., Balla, J.: Oxidation of hemoglobin drives a proatherogenic polarization of macrophages in human atherosclerosis.
Antioxid. Redox Signal. 35 (12), 917-950, 2021.
Folyóirat-mutatók:
D1 Biochemistry
Q1 Cell Biology
D1 Clinical Biochemistry
D1 Medicine (miscellaneous)
Q1 Molecular Biology
D1 Physiology
2020
9.
Zavaczki, E., Gáll, T., Zarjou, A., Hendrik, Z., Potor, L., Tóth, C., Méhes, G., Gyetvai, Á., Agarwal, A., Balla, G., Balla, J.: Ferryl Hemoglobin Inhibits Osteoclastic Differentiation of Macrophages in Hemorrhaged Atherosclerotic Plaques.
Oxidative Medicine and Cellular Longevity. 2020, 1-17, 2020.
Folyóirat-mutatók:
Q2 Aging
Q1 Biochemistry
Q2 Cell Biology
Q1 Medicine (miscellaneous)
10.
Posta, N., Csősz, É., Oros, M., Pethő, D., Potor, L., Kalló, G., Hendrik, Z., Sikura, K. É., Méhes, G., Tóth, C., Posta, J., Balla, G., Balla, J.: Hemoglobin oxidation generates globin-derived peptides in atherosclerotic lesions and intraventricular hemorrhage of the brain, provoking endothelial dysfunction.
Lab. Invest. 100 (7), 986-1002, 2020.
Folyóirat-mutatók:
Q2 Cell Biology
Q2 Molecular Biology
Q1 Pathology and Forensic Medicine
11.
Sikura, K. É., Potor, L., Szerafin, T., Oros, M., Nagy, P., Méhes, G., Hendrik, Z., Zarjou, A., Agarwal, A., Posta, N., Torregrossa, R., Whiteman, M., Fürtös, I., Balla, G., Balla, J.: Hydrogen sulfide inhibits calcification of heart valves; implications for calcific aortic valve disease.
Br. J. Pharmacol. 177 (4), 793-809, 2020.
Folyóirat-mutatók:
D1 Pharmacology
12.
Potor, L., Sikura, K. É., Hegedűs, H., Pethő, D., Szabó, Z., Máthéné Szigeti, Z., Pócsi, I., Trencsényi, G., Szikra, D. P., Garai, I., Gáll, T., Combi, Z., Kappelmayer, J., Balla, G., Balla, J.: The Fungal Iron Chelator Desferricoprogen Inhibits Atherosclerotic Plaque Formation.
Int. J. Mol. Sci. 21 (13), 1-23, 2020.
Folyóirat-mutatók:
Q2 Catalysis
D1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
D1 Physical and Theoretical Chemistry
D1 Spectroscopy
2019
13.
Sikura, K. É., Potor, L., Szerafin, T., Zarjou, A., Agarwal, A., Arosio, P., Poli, M., Hendrik, Z., Méhes, G., Oros, M., Posta, N., Beke, L., Fürtös, I., Balla, G., Balla, J.: Potential Role of H-Ferritin in Mitigating Valvular Mineralization.
Arterioscler. Thromb. Vasc. Biol. 39 (3), 413-431, 2019.
Folyóirat-mutatók:
D1 Cardiology and Cardiovascular Medicine
2018
14.
Gáll, T., Pethő, D., Nagy, A., Hendrik, Z., Méhes, G., Potor, L., Gram, M., Akerström, B., Smith, A., Nagy, P. F., Balla, G., Balla, J.: Heme Induces Endoplasmic Reticulum Stress (HIER Stress) in Human Aortic Smooth Muscle Cells.
Front. Physiol. 9, 1-25, 2018.
Folyóirat-mutatók:
Q2 Physiology
Q2 Physiology (medical)
15.
Potor, L., Nagy, P., Méhes, G., Hendrik, Z., Jeney, V., Pethő, D., Vasas, A., Pálinkás, Z., Balogh, E., Gyetvai, Á., Whiteman, M., Torregrossa, R., Wood, M. E., Olvasztó, S., Nagy, P. F., Balla, G., Balla, J.: Hydrogen Sulfide Abrogates Hemoglobin-Lipid Interaction In Atherosclerotic Lesion.
Oxidative Med. Cell. Longev. 2018, 1-16, 2018.
Folyóirat-mutatók:
Q2 Aging
Q1 Biochemistry
Q2 Cell Biology
Q1 Medicine (miscellaneous)
2016
16.
Balla, J., Zarjou, A., Agarwal, A., Becs, G., Sikura, K. É., Nyitrai, M., Potor, L., Pethő, D., Oros, M., Zavaczki, E., Arosio, P., Eaton, J. W., Balla, G.: Role of heme in soft tissue mineralization.
Free Radic. Biol. Med. 96, S13, 2016.
2014
17.
Jeney, V., Potor, L., Pethő, D., Whiteman, M., Wood, M. E., Balla, G., Balla, J.: Hydrogen-sulfide releasing molecules inhibit intraplaque hemorrhage-associated oxidative burst in the human atheroma and subsequent endothelial reactions.
Nitric Oxide-Biol. Chem. 39, S45-S46, 2014.
2013
18.
Potor, L., Bányai, E., Becs, G., Soares, M. P., Balla, G., Balla, J., Jeney, V.: Atherogenesis May Involve the Prooxidant and Proinflammatory Effects of Ferryl Hemoglobin.
Oxid. Med. Cell. Longev. 2013, [1-13], 2013.
Folyóirat-mutatók:
Q2 Aging
Q2 Biochemistry
Q3 Cell Biology
Q1 Medicine (miscellaneous)
19.
Jeney, V., Silva, G., Potor, L., Balla, G., Soares, M. P., Balla, J.: Ferryl hemoglobin is a proinflammatory agonist that activates endothelial cells and induces mouse peritonitis.
Am. J. Hematol. 88 (5), E234-E235, 2013.
20.
Jeney, V., Potor, L., Whiteman, M., Wood, M. E., Balla, G., Balla, J.: Potential anti-atherogenic effects of hydrogen-sulfide releasing molecules.
Nitric Oxide-Biol. Chem. 31, S61, 2013.
DEENK Debreceni Egyetem
© 2012 Debreceni Egyetem